Streptomycin (incl. BSA conjugate) Mouse Monoclonal Antibody [Clone ID: CH-2013]

CAT#: BM2095

Streptomycin (incl. BSA conjugate) mouse monoclonal antibody, clone CH-2013, Ascites

Specifications

Product Data

• Clone Name: CH-2013
• Applications: ELISA, R
• Recommended Dilution: ELISA: 1/1500.
  Sensitivity: Approximately 100 pg/ml streptomycin and dihydrostreptomycin when used with the included conjugate (see "Additional Information").
• Host: Mouse
• Isotype: IgG1
• Clonality: Monoclonal
• Specificity: Streptomycin, dihydrostreptomycin.
  Does not react with other aminoglycoside antibiotics such as gentamicin, kanamycin, etc., other classes of antibiotics, or milk and serum proteins.
• Formulation: PBS, containing 0.05 % Sodium Azide as preservative
  State: Ascites
  State: Liquid diluted ascites
• Storage: Ship at 2-8°C, aliquot and store the antibody at -20°C. Avoid repeated freezing and thawing.
• Stability: Shelf life: One year from despatch.
• Background: Streptomycin is an antibiotic produced by soil bacteria of the genus Streptomyces and is active against both gram positive and gram negative bacteria, including species resistant to other antibiotics, eg some streptococci, penicillin resistant staphylococci, and bacteria of the genera Proteus and Pseudomonas. Originally isolated by Selman A. Waksman and Albert Schatz in 1947, streptomycin is effective against tubercle bacilli and is a mainstay of tuberculosis therapy. Because streptomycin resistant tubercle bacilli emerge during treatment, the antibiotic is usually used in combination with one or more of the drugs isoniazid, ethambutol, and aminosalicylic acid. Streptomycin acts by inhibiting protein synthesis and damaging cell membranes in susceptible microorganisms. Possible side effects include injury to the kidneys and nerve damage that can result in dizziness and deafness.
• Note: Includes BSA Conjugated Control
  Format: Purified, Liquid
  Buffer: PBS with 0.05% Sodium Azide
  Applications: A standard dilution of 1/1,500 is suggested for ELISA.